ENDRA Life Sciences Reports Second Quarter 2022 Financial Results and Provides Business Update

Go back to ENDRA Life Sciences Reports Second Quarter 2022 Financial Results and Provides Business Update

ENDRA Life Sciences (NDRA) Reports In-Line Q2 EPS

August 15, 2022 4:52 PM EDT

ENDRA Life Sciences (NASDAQ: NDRA) reported Q2 EPS of ($0.06), in-line with the analyst estimate of ($0.06).

For earnings history and earnings-related data on ENDRA Life Sciences (NDRA) click here.

... More